16-31180161-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004960.4(FUS):​c.-54A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.991 in 1,599,102 control chromosomes in the GnomAD database, including 785,741 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.95 ( 69189 hom., cov: 35)
Exomes 𝑓: 0.99 ( 716552 hom. )

Consequence

FUS
NM_004960.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.722

Publications

22 publications found
Variant links:
Genes affected
FUS (HGNC:4010): (FUS RNA binding protein) This gene encodes a multifunctional protein component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex. The hnRNP complex is involved in pre-mRNA splicing and the export of fully processed mRNA to the cytoplasm. This protein belongs to the FET family of RNA-binding proteins which have been implicated in cellular processes that include regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. Alternative splicing results in multiple transcript variants. Defects in this gene result in amyotrophic lateral sclerosis type 6. [provided by RefSeq, Sep 2009]
FUS Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • amyotrophic lateral sclerosis type 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • juvenile amyotrophic lateral sclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tremor, hereditary essential, 4
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 16-31180161-A-G is Benign according to our data. Variant chr16-31180161-A-G is described in ClinVar as [Benign]. Clinvar id is 318979.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FUSNM_004960.4 linkc.-54A>G 5_prime_UTR_variant Exon 1 of 15 ENST00000254108.12 NP_004951.1 P35637-1Q6IBQ5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FUSENST00000254108.12 linkc.-54A>G 5_prime_UTR_variant Exon 1 of 15 1 NM_004960.4 ENSP00000254108.8 P35637-1

Frequencies

GnomAD3 genomes
AF:
0.950
AC:
144592
AN:
152190
Hom.:
69145
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.827
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.980
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.994
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.961
GnomAD2 exomes
AF:
0.987
AC:
220268
AN:
223204
AF XY:
0.991
show subpopulations
Gnomad AFR exome
AF:
0.814
Gnomad AMR exome
AF:
0.990
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.999
Gnomad OTH exome
AF:
0.995
GnomAD4 exome
AF:
0.995
AC:
1439425
AN:
1446794
Hom.:
716552
Cov.:
45
AF XY:
0.996
AC XY:
715182
AN XY:
718302
show subpopulations
African (AFR)
AF:
0.826
AC:
27450
AN:
33244
American (AMR)
AF:
0.989
AC:
41747
AN:
42222
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
25783
AN:
25784
East Asian (EAS)
AF:
1.00
AC:
39038
AN:
39038
South Asian (SAS)
AF:
1.00
AC:
84037
AN:
84072
European-Finnish (FIN)
AF:
1.00
AC:
52036
AN:
52036
Middle Eastern (MID)
AF:
0.996
AC:
5723
AN:
5746
European-Non Finnish (NFE)
AF:
1.00
AC:
1104493
AN:
1104850
Other (OTH)
AF:
0.989
AC:
59118
AN:
59802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
348
696
1044
1392
1740
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21566
43132
64698
86264
107830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.950
AC:
144695
AN:
152308
Hom.:
69189
Cov.:
35
AF XY:
0.951
AC XY:
70863
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.827
AC:
34359
AN:
41540
American (AMR)
AF:
0.980
AC:
15010
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3471
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5160
AN:
5160
South Asian (SAS)
AF:
1.00
AC:
4831
AN:
4832
European-Finnish (FIN)
AF:
1.00
AC:
10630
AN:
10630
Middle Eastern (MID)
AF:
0.993
AC:
292
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67997
AN:
68042
Other (OTH)
AF:
0.961
AC:
2033
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
340
681
1021
1362
1702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.992
Hom.:
101830
Bravo
AF:
0.943
Asia WGS
AF:
0.992
AC:
3451
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis type 6 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
12
DANN
Benign
0.63
PhyloP100
0.72
PromoterAI
-0.016
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs929867; hg19: chr16-31191482; API